Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952777 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Homeobox B3 (HOXB3) (AA 118-148), (Middle Region) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 118-148, Middle Region
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression.
HOX gene analysis of endothelial cell differentiation in human bone marrow-derived mesenchymal stem cells.
Induction of HoxB transcription by retinoic acid requires actin polymerization.
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias.
Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics.
Palakurthy RK, Wajapeyee N, Santra MK, Gazin C, Lin L, Gobeil S, Green MR
Molecular cell 2009 Oct 23;36(2):219-30
Molecular cell 2009 Oct 23;36(2):219-30
HOX gene analysis of endothelial cell differentiation in human bone marrow-derived mesenchymal stem cells.
Chung N, Jee BK, Chae SW, Jeon YW, Lee KH, Rha HK
Molecular biology reports 2009 Feb;36(2):227-35
Molecular biology reports 2009 Feb;36(2):227-35
Induction of HoxB transcription by retinoic acid requires actin polymerization.
Ferrai C, Naum-Onganía G, Longobardi E, Palazzolo M, Disanza A, Diaz VM, Crippa MP, Scita G, Blasi F
Molecular biology of the cell 2009 Aug;20(15):3543-51
Molecular biology of the cell 2009 Aug;20(15):3543-51
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias.
Speleman F, Cauwelier B, Dastugue N, Cools J, Verhasselt B, Poppe B, Van Roy N, Vandesompele J, Graux C, Uyttebroeck A, Boogaerts M, De Moerloose B, Benoit Y, Selleslag D, Billiet J, Robert A, Huguet F, Vandenberghe P, De Paepe A, Marynen P, Hagemeijer A
Leukemia 2005 Mar;19(3):358-66
Leukemia 2005 Mar;19(3):358-66
Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics.
Roche J, Zeng C, Barón A, Gadgil S, Gemmill RM, Tigaud I, Thomas X, Drabkin HA
Leukemia 2004 Jun;18(6):1059-63
Leukemia 2004 Jun;18(6):1059-63
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC